FDA Inspection
BIPSO GmbHBIPSO GmbH – FDA Inspection, May 4, 2022
Record Details
This FDA Inspection record concerns BIPSO GmbH, with an inspection on May 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- BIPSO GmbH
- Inspection Date
- May 4, 2022
- Product Type
- Drugs
View Company Profile
ID · 0c873610-d7eb-4826-944f-d809534248bd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1278362
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of BIPSO GmbH
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2018 | Not classified | Office of Inspections and Investigations | |
| June 17, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 11, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 10, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BIPSO GmbH
- FDA Inspection 1125102 - 2019-11-07
- FDA Inspection 1058876 - 2018-05-30
- FDA Inspection 986231 - 2016-06-17
- FDA Inspection 868627 - 2014-02-11
- FDA Inspection 784924 - 2012-05-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.